av/takeda--big.svg

COM:TAKEDA

Takeda Pharmaceutical Company Limited

  • Stock

JPY

Last Close

4,113.00

25/11 06:45

Market Cap

6.77T

Beta: -

Volume Today

9.61M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
average inventory
241.93B
-
258.34B
6.78%
258.18B
0.06%
240.15B
6.98%
219.62B
8.55%
599.84B
173.13%
873.17B
45.57%
756.74B
13.33%
803.52B
6.18%
919.81B
14.47%
1.10T
19.39%
average payables
151.80B
-
177.84B
17.16%
180.94B
1.74%
215.86B
19.30%
240.44B
11.39%
226.30B
5.88%
265.58B
17.36%
331.33B
24.76%
430.07B
29.80%
582.76B
35.51%
313.70B
46.17%
average receivables
514.17B
-
454.75B
11.56%
448.70B
1.33%
437.67B
2.46%
436.79B
0.20%
588.96B
34.84%
767.02B
30.23%
798.82B
4.15%
768.55B
3.79%
703.03B
8.52%
689.65B
1.90%
book value per share
3.13K
-
2.72K
13.17%
2.49K
8.53%
2.43K
2.44%
2.56K
5.48%
5.37K
109.77%
3.03K
43.47%
3.31K
9.18%
3.63K
9.75%
4.09K
12.65%
4.65K
13.55%
capex per share
-99.46
-
-138.25
39.00%
-108.24
21.70%
-143.42
32.50%
-164.27
14.53%
-139.49
15.09%
-139.81
0.23%
-151.39
8.28%
-118.99
21.40%
-408.36
243.19%
307.28
175.25%
capex to depreciation
-0.36
-
-0.42
14.47%
-0.43
3.19%
-0.50
16.96%
-0.70
40.05%
-0.49
30.10%
-0.37
24.22%
-0.42
13.27%
-0.32
24.49%
-0.95
198.97%
0.66
169.23%
capex to operating cash flow
-0.53
-
-0.60
12.53%
-3.33
458.86%
-0.43
87.12%
-0.34
20.81%
-0.41
20.28%
-0.33
20.38%
-0.23
28.04%
-0.17
29.18%
-0.65
291.50%
0.67
203.48%
capex to revenue
-0.05
-
-0.06
31.75%
-0.05
23.22%
-0.06
37.76%
-0.07
12.00%
-0.06
11.73%
-0.07
3.44%
-0.07
11.79%
-0.05
29.51%
-0.16
201.85%
0.11
171.66%
cash per share
1.08K
-
907.20
15.84%
714.37
21.26%
481.55
32.59%
480.48
0.22%
754.43
57.01%
419.62
44.38%
642.01
53.00%
559.64
12.83%
356.81
36.24%
302.27
15.29%
days of inventory on hand
189.35
-
183.80
2.93%
173.17
5.79%
147.82
14.63%
156.73
6.02%
545.96
248.35%
254.42
53.40%
276.74
8.78%
281.35
1.66%
289.42
2.87%
308.49
6.59%
days payables outstanding
137.66
-
119.65
13.08%
130.27
8.88%
157.18
20.66%
176.83
12.50%
117.49
33.56%
106.78
9.11%
126.22
18.20%
170.26
34.89%
190.48
11.88%
81.58
57.17%
days sales outstanding
95.51
-
95.84
0.35%
86.95
9.28%
93.73
7.79%
88.40
5.69%
130.38
47.49%
87.05
33.23%
92.76
6.56%
74.08
20.14%
61.78
16.61%
59.72
3.34%
debt to assets
0.19
-
0.17
9.80%
0.20
18.33%
0.26
30.84%
0.24
8.68%
0.41
72.72%
0.40
4.17%
0.36
9.63%
0.33
8.15%
0.31
4.78%
0.32
2.11%
debt to equity
0.35
-
0.34
1.94%
0.39
15.51%
0.60
53.31%
0.49
18.35%
1.11
125.87%
1.08
3.26%
0.90
16.90%
0.76
14.67%
0.69
9.80%
0.67
3.44%
dividend yield
0.04
-
0.03
18.42%
0.04
17.09%
0.03
1.32%
0.04
1.07%
0.03
7.63%
0.05
69.39%
0.05
17.02%
0.05
13.94%
0.04
20.19%
0.04
6.63%
earnings yield
0.03
-
-0.03
211.89%
0.02
164.43%
0.03
41.34%
0.05
64.10%
0.02
46.47%
0.01
65.26%
0.06
603.35%
0.04
30.36%
0.05
11.64%
0.02
52.85%
enterprise value
4.06T
-
4.79T
18.21%
4.34T
9.42%
4.91T
13.05%
4.74T
3.50%
9.46T
99.72%
9.61T
1.52%
9.89T
2.99%
8.96T
9.39%
10.60T
18.23%
10.89T
2.77%
enterprise value over ebitda
10.01
-
32.31
222.89%
12.41
61.58%
12.61
1.57%
10.99
12.87%
25.14
128.84%
13.97
44.45%
8.42
39.68%
8.52
1.13%
8.77
2.89%
12.45
42.08%
ev to operating cash flow
27.34
-
26.27
3.92%
170.38
548.55%
18.79
88.97%
12.54
33.25%
28.81
129.74%
14.34
50.21%
9.79
31.77%
7.98
18.44%
10.85
35.89%
15.21
40.18%
ev to sales
2.40
-
2.70
12.49%
2.40
10.90%
2.83
17.96%
2.68
5.59%
4.51
68.61%
2.92
35.31%
3.09
5.99%
2.51
18.81%
2.63
4.77%
2.55
2.93%
free cash flow per share
88.43
-
93.84
6.12%
-75.73
180.69%
191.19
352.47%
319.66
67.20%
202.15
36.76%
290.29
43.60%
495.81
70.80%
599.34
20.88%
221.33
63.07%
150.61
31.96%
free cash flow yield
0.02
-
0.02
13.46%
-0.01
194.25%
0.04
347.98%
0.06
68.68%
0.04
28.60%
0.09
99.29%
0.12
41.78%
0.17
37.71%
0.05
70.30%
0.04
28.83%
graham net net
-909.87
-
-1.14K
25.12%
-1.02K
10.04%
-2.03K
97.99%
-1.65K
18.79%
-7.21K
337.57%
-4.16K
42.32%
-3.68K
11.49%
-3.61K
1.77%
-3.90K
7.80%
-3.98K
2.29%
graham number
3.08K
-
3.37K
9.15%
2.39K
28.96%
2.83K
18.49%
3.71K
30.99%
3.70K
0.26%
1.39K
62.38%
4.24K
204.15%
3.47K
18.09%
4.34K
25.06%
3.10K
28.46%
income quality
1.35
-
-1.28
194.25%
0.31
123.93%
2.26
640.98%
2.02
10.56%
3.01
48.89%
15.12
401.86%
2.69
82.23%
4.88
81.57%
3.08
36.84%
4.97
61.33%
intangibles to total assets
0.43
-
0.41
3.95%
0.40
2.89%
0.48
20.44%
0.50
3.78%
0.65
30.69%
0.64
1.85%
0.62
3.63%
0.62
1.48%
0.65
3.99%
0.64
1.25%
interest coverage
4.53
-
-3.93
186.71%
4.10
204.22%
6.70
63.62%
7.57
12.96%
4.26
43.80%
0.61
85.70%
2.05
236.61%
2.77
35.04%
2.89
4.50%
1.39
51.79%
interest debt per share
1.13K
-
969.30
14.09%
1.02K
5.30%
1.50K
46.52%
1.30K
12.86%
6.03K
362.80%
3.38K
44.01%
3.13K
7.40%
2.89K
7.70%
2.93K
1.65%
3.19K
8.90%
inventory turnover
1.93
-
1.99
3.02%
2.11
6.14%
2.47
17.14%
2.33
5.68%
0.67
71.29%
1.43
114.59%
1.32
8.07%
1.30
1.64%
1.26
2.79%
1.18
6.18%
invested capital
0.35
-
0.34
1.94%
0.39
15.51%
0.60
53.31%
0.49
18.35%
1.11
125.87%
1.08
3.26%
0.90
16.90%
0.76
14.67%
0.69
9.80%
11.92T
1,728,326,328,379,321%
market cap
3.86T
-
4.72T
22.15%
4.03T
14.65%
4.08T
1.44%
4.05T
0.92%
4.41T
9.07%
5.15T
16.70%
6.22T
20.84%
5.47T
12.14%
6.75T
23.43%
6.51T
3.61%
net current asset value
-435.97B
-
-569.94B
30.73%
-439.10B
22.96%
-1.15T
161.03%
-1.01T
11.86%
-5.66T
460.07%
-5.62T
0.60%
-5.02T
10.70%
-4.90T
2.42%
-5.21T
6.21%
-5.28T
1.37%
net debt to ebitda
0.48
-
0.52
8.77%
0.91
73.98%
2.12
134.10%
1.60
24.40%
13.41
737.02%
6.48
51.71%
3.12
51.77%
3.32
6.34%
3.18
4.18%
5.01
57.55%
net income per share
135.10
-
-185.37
237.21%
102.26
155.17%
147.15
43.90%
239.35
62.65%
113.50
52.58%
28.41
74.97%
240.72
747.29%
147.14
38.87%
204.29
38.84%
92.09
54.92%
operating cash flow per share
187.89
-
232.09
23.52%
32.52
85.99%
334.61
929.05%
483.92
44.62%
341.64
29.40%
430.10
25.89%
647.20
50.48%
718.33
10.99%
629.69
12.34%
457.89
27.28%
payables turnover
2.65
-
3.05
15.05%
2.80
8.15%
2.32
17.12%
2.06
11.11%
3.11
50.51%
3.42
10.03%
2.89
15.40%
2.14
25.87%
1.92
10.62%
4.47
133.49%
receivables turnover
3.82
-
3.81
0.35%
4.20
10.22%
3.89
7.23%
4.13
6.03%
2.80
32.20%
4.19
49.77%
3.93
6.16%
4.93
25.22%
5.91
19.91%
6.11
3.45%
research and ddevelopement to revenue
0.20
-
0.21
6.45%
0.19
10.95%
0.18
5.79%
0.18
1.94%
0.18
4.46%
0.15
14.81%
0.14
4.72%
0.15
3.41%
0.16
6.68%
0.17
8.87%
return on tangible assets
0.04
-
-0.06
241.20%
0.03
160.57%
0.05
45.55%
0.09
78.70%
0.02
75.17%
0.01
57.59%
0.08
693.11%
0.05
38.60%
0.06
39.33%
0.03
58.97%
revenue per share
2.14K
-
2.26K
5.50%
2.31K
1.98%
2.22K
3.82%
2.27K
2.26%
2.18K
3.81%
2.11K
3.11%
2.05K
3.14%
2.28K
11.50%
2.60K
13.70%
2.73K
5.01%
roe
0.04
-
-0.07
258.02%
0.04
160.31%
0.06
47.50%
0.09
54.20%
0.02
77.39%
0.01
55.72%
0.07
676.04%
0.04
44.31%
0.05
23.24%
0.02
60.30%
roic
0.03
-
-0.04
253.77%
0.03
175.20%
0.04
23.93%
0.07
68.58%
0.02
69.02%
-0.01
134.55%
0.05
815.23%
0.03
34.45%
0.04
10.46%
0.05
24.97%
sales general and administrative to revenue
shareholders equity per share
3.13K
-
2.72K
13.17%
2.49K
8.53%
2.43K
2.44%
2.56K
5.48%
5.37K
109.77%
3.03K
43.47%
3.31K
9.18%
3.63K
9.75%
4.09K
12.65%
4.65K
13.54%
stock based compensation to revenue
-0.13
-
-0.06
48.68%
-0.03
59.64%
-0.09
252.74%
0.01
111.38%
0.01
8.89%
0.01
7.60%
0.01
33.10%
0.01
3.19%
0.02
23.96%
0.02
10.34%
tangible asset value
590.37B
-
444.88B
24.64%
488.76B
9.86%
-139.58B
128.56%
-26.10B
81.30%
-3.86T
14,680.61%
-3.46T
10.41%
-2.77T
19.98%
-2.54T
8.07%
-2.71T
6.41%
-2.41T
10.90%
tangible book value per share
747.80
-
565.72
24.35%
623.46
10.21%
-178.70
128.66%
-33.43
81.29%
-4.01K
11,903.28%
-2.22K
44.69%
-1.77K
20.23%
-1.63K
8.15%
-1.74K
7.21%
-1.54K
11.62%
working capital
789.78B
-
503.25B
36.28%
516.57B
2.65%
-105.43B
120.41%
341.30B
423.72%
539.73B
58.14%
293.53B
45.61%
939.72B
220.14%
447.91B
52.34%
-83.98B
118.75%
245.48B
392.29%

All numbers in JPY (except ratios and percentages)